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Abstract
Purpose of Review The aim of this report is to identify rele-
vant literature reports on salvage transoral laser microsurgery
(TLM); to consider its oncologic and functional outcomes, as
well as reported complications; and to address indications and
limitations of salvage TLM.
Findings The weighted average of local control after first sal-
vage TLMwas 57%. Repeated TLM procedures for second or
third recurrences were required in up to 41% of cases,
resulting in a weighted average of local control with TLM
alone of 67%. The rate of definite laryngeal preservation
was 73%. The ultimate local control rate, including cases that
required total laryngectomy, was 90%. The overall complica-
tion rate after salvage TLM was 14%.
Summary Salvage TLM of radiorecurrent laryngeal cancer
yields excellent oncologic outcomes. Serious complications
are scarce, hospitalization times are short, and functional out-
comes in terms of voice and swallowing are favorable when
compared to open conservation laryngeal surgery. The key to
success is an optimal patient selection.
Keywords Conservation surgery . Laryngeal cancer . Salvage
surgery . Transoral laser microsurgery . Squamous cell
carcinoma
Introduction
Radiotherapy (RT) is widely used in the primary management of
early laryngeal squamous cell carcinoma (SCC) with good func-
tional and oncologic results. The reported rates of local control
with RTalone for T1 glottic SCC range from 84 to 95% [1]. For
T2 glottic tumors, local control rates between 50 and 85% have
been reported [1]. Concerning early supraglottic SCC, 5-year
local control rates up to 100% for T1 lesions and up to 86%
for T2 tumors were achieved after primary irradiation [2, 3].
When these laryngeal cancers recur after primary radiation treat-
ment, surgical salvage in the form of total laryngectomy (TL) has
traditionally been the gold standard with good oncologic out-
comes [4, 5]. However, in selected cases, salvage conservation
laryngeal surgery may be considered as a more functional alter-
native to TL. This encompasses both open surgical techniques
such as horizontal supraglottic laryngectomy, vertical partial lar-
yngectomy, supracricoid partial laryngectomy, and extended
hemilaryngectomy with tracheal autotransplantation on the one
hand and transoral techniques such as transoral laser microsur-
gery (TLM) and transoral robotic surgery (TORS) on the other
[6, 7]. Whereas open salvage conservation laryngeal surgery has
good oncologic outcomes in experienced hands, its widespread
use is hampered due to the technical complexity of the proce-
dures, the lack of expertise in most centers, unpredictable
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functional outcomes regarding voice and swallowing, high rates
of complications (fistula formation and aspiration pneumonia),
and long hospitalization time [7, 8••]. On the other hand, TLM
has a proven track record in the primary management of glottic
and supraglottic cancer, yielding excellent local control rates
comparable to primary irradiation, but the role of TLM as a
salvage treatment for radiorecurrent laryngeal cancer is less elu-
cidated [1, 9, 10, 11••]. Its first description dates from the mid-
1980s, when two different low volume series of 10 and 15 pa-
tients reported local control rates of 50 and 40%, respectively
[12, 13]. The aim of this report is to identify relevant literature
reports on salvage TLM and to summarize its oncologic and
functional outcomes, reported complications, indications, and
limitations.
Materials and Methods
The primary search for this review was conducted in
September 2016 using the MEDLINE database including the
literature published from 1995 to 2016. The following search
strategies were used: “Salvage TLM” or “Salvage Therapy
[MESH] AND Laser Therapy [MESH] AND Laryngeal
Neoplasm [MESH],” yielding 20 and 37 results, respectively.
Initially, no limitations on the search were imposed and peer-
reviewed journals in all languages were included. Abstracts
and titles were screened for relevance, and the full articles of
the selected records were reviewed. The reference lists of rel-
evant papers were scrutinized to identify additional papers of
potential interest. Inclusion criteria for articles at this stage
were English language, published series of 10 or more cases,
transoral laser treatment of recurrent laryngeal cancer (glottic
or supraglottic subsite) after primary RT or chemo-RT. After
excluding papers which did not meet the listed criteria and
after removing duplicates, 14 articles were finally included.
Oncologic and functional outcomes and complications were
recorded and analyzed, and statements concerning indications
and/or limitations of salvage TLM which were based on ob-
jective results or the experience of the authors were reviewed
and summarized. Weighted averages of local control and la-
ryngeal preservation rates were calculated in this manner: for
each included paper, the product of the reported average local
control/laryngeal preservation rates with the number of in-
cluded patients was determined. The sum of these products
was calculated and subsequently divided by the total number
of patients included in all papers.
Results
Fourteen papers form the basis for this review: 13 are retro-
spective descriptive series and 1 is a two-center prospective
case series [14], with a population size ranging between 10
and 53 subjects. The series of Puxeddu et al. [15] is a two-
center retrospective case series, with results of one included
center updated in a later publication by Piazza et al. [16],
which, in turn, was updated by Del Bon et al. [17]. Most
authors reported on series of rT1 to rT2 glottic cancer, while
some authors also included more advanced glottic cases (rT3
or even rT4) [11••, 18–21] or supraglottic recurrences [14, 18,
20–22].
Oncologic Outcomes
Overall Population
Oncologic results as reported in the 14 included papers are
listed in Table 1 [11••, 14–26]. The follow-up ranged from
0.3 to 215 months, with the reported mean and median (de-
pending on the series) follow-up ranging from 25.2 to
87.9 months. Local control after a first salvage TLM proce-
dure for recurrent laryngeal cancer varied between 38 and
81%, with a weighted average among studies of 57%. One
study reported on a 2-year estimated local control rate of 88%
[14]. Repeated TLM procedures for a second or third recur-
rence were required in up to 41% of cases, resulting in local
control rates with TLM alone varying between 50 and 87%,
with a weighted average of 67%. The rates of definite laryn-
geal preservation, as obtained after TLM alone or a combina-
tion of TLM and salvage open partial laryngectomy, ranged
from 50 to 94%with a weighted average of 73%. The ultimate
local control rate, including cases that required salvage TL due
to failure of salvage TLM, was 80 to 100%, with a weighted
average of 90%. Concerning disease-specific survival (DSS)
and overall survival (OS), variability in reporting is noticed,
with some papers only giving the number of disease- and non-
disease-related deaths during follow-up allowing for recon-
struction of DSS and OS rates at the end of follow up, while
other authors communicate the Kaplan-Meier estimates of 3-
and/or 5-year OS and DSS. Regarding OS, 3-year estimates of
67.5 to 93.7% and 5-year estimates of 53 to 91% are reported.
For DSS, 3-year and 5-year estimates both ranging between
68.6 and 100% were encountered in the included literature.
Anterior Commissure Involvement
Most studies give details about the rate of patients with ante-
rior commissure (AC) involvement and the oncologic out-
comes of this subgroup. Most authors noticed higher rates of
the development of a second recurrence following salvage
TLM in patients with AC involvement when compared to
patients with the AC free of tumor: second recurrence rates
of 50 versus 11% [18], 71 versus 48% [23], 67 versus 8% [15],
and 55 versus 29% [24], respectively, were reported. On uni-
variate analysis, Han et al. identified AC involvement as a
negative prognostic factor for 3-and 5-year local control rates
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(51.9 versus 85.7% and 0 versus 64.2%, p = 0.09) [24]. This
trend towards lower local control was not confirmed by data
from Steiner et al. [11••] and Del Bon et al. [17]. However,
Steiner et al. did observe a higher rate of salvage laryngecto-
mies in patients with AC involvement (29 versus 8%) [11••],
which was also observed by De Gier et al. (59 versus 44%)
[23] and Roedel et al. (39 versus 16%) [19].
Early-Stage Versus Advanced-Stage Recurrences
Most authors did observe a lower local control rate in groups
with advanced-stage recurrence (rT3–rT4) when compared to
early-stage recurrent carcinomas (rT1–rT2). Steiner et al.
demonstrated a slightly lower number of local recurrences
and salvage laryngectomies in patients with early-stage recur-
rent carcinomas versus advanced-stage recurrences (57 versus
62%; 19 versus 23%) [11••]. Ansarin et al. observed a signif-
icantly worse estimated 5-year recurrence-free survival (RFS)
rate among patients with locally advanced recurrent cancer
treated with salvage TLM (rT3): he observed a 5-year RFS
of 0% for rT3 patients (n = 4) versus 61 and 65% for rT2 and
rT1 patients, respectively [25]. Interestingly, Han et al. dem-
onstrated, within a group of early-stage recurrent glottic can-
cer, a significant higher 3-year and 5-year local control rates in
patients with a rT1 tumor versus patients with a rT2 tumor
(87.5 versus 44.4% and 87.5 versus 16.6%, p = 0.02). The
same was true for 3-year and 5-year laryngeal preservation
rates (87.5 versus 44.4% and 87.5 versus 33.3%, p = 0.03)
[24]. Moreover, Del Bon et al. discovered on univariate anal-
ysis that the rpT category had a statistically significant impact
on local control with laser alone (100% for rpT1, 67% for
rpT2, and 50% for rpT3), both in the entire cohort and in the
group with true persistent and recurrent disease, excluding
second primary glottic carcinomas in a previously irradiated
area [17]. In contrast to the compromised local control in
advanced-stage cases, DSS and/or OS did not prove to be
significantly different between early-stage and advanced-
stage recurrences, but this may turn out to be different in larger
cohorts with longer follow-up [11••, 17, 19].
Functional Outcomes and Complications
The functional outcomes and complications after salvage
TLM are outlined in Table 2. The mean hospitalization
time varied between 2.2 and 9 days. Tracheotomy was
not required as a routine procedure (in contrast to open
partial laryngeal surgery) with most studies reporting a
0% tracheotomy rate. However, in four series [11••, 20,
21, 24], postoperative tracheotomy proved necessary in 2
to 22% of cases, with decannulation times ranging from
4 days to more than 4 months. The nasogastric tube feed-
ing rate ranged from 0 to 23.5% with all nasogastric tubes
being removed after 8 days. Three studies reported cases
in which long-term gastrostomy tube (G-tube) feeding
was required [19–21]. However, two of these studies, in
which both glottic and supraglottic recurrences were in-
cluded, reported—as expected—higher G-tube dependen-
cy in the supraglottic recurrences when compared to the
glottic cancer recurrences (60 versus 20% [20] and 79
versus 21% [21]). When all patients of the included stud-
ies were taken into account (n = 350), postoperative tra-
cheotomy need and G-tube requirement were only 2.3%
(n = 8) and 6.6% (n = 23), respectively. Concerning vocal
outcomes after salvage TLM, only limited data are avail-
able, with most studies being retrospective and stating that
postoperative voice is considered to be functional or
acceptable in the majority of cases. Puxeddu et al. com-
municated postoperative perceptual voice evaluation
(grade, roughness , breathiness , as thenia , s t ra in
(GRBAS)) outcomes, showing mild, moderate, and severe
dysphonia in 12.5, 25, and 37.5% of patients, respective-
ly. Laryngostroboscopy showed an incomplete glottal clo-
sure in 56% of patients [15]. Fink et al. observed a sig-
nificant increase in mean voice handicap index (VHI)
(from 31.8 preoperatively to 53.5 postoperatively,
p = 0.026) and decrease in perceptual score (from 57.0
to 45.3, p = 0.017) in patients who underwent salvage
TLM for glottic recurrences [21]. Of interest is the func-
tional analysis by Del Bon et al., who retrospectively
compared 10 salvage TLM patients with 10 patients treat-
ed by primary TLM, after matching for age, gender, and
pT category. At least 2 years after surgery, both groups
were evaluated with a comprehensive voice assessment,
including VHI, perceptual GRBAS scale, and objective
analysis with the multidimensional voice program
(MDVP). Swallowing was evaluated by completion of
the M.D. Anderson Dysphagia Inventory (MDADI),
fiberoptic endoscopic examination of swallowing
(FEES), and videofluoroscopy (VFS). No statistically sig-
nificant differences in functional outcomes were observed
between the salvage and primary TLM groups [17].
However, this finding seems contradictory to the authors’
clinical feeling that functional outcome, especially
concerning voice, after salvage TLM, is consistently
poorer when compared with primary cases. Future com-
parative analyses with larger patient cohorts will be nec-
essary to address this issue. The overall complication rate
after salvage TLM amounted to 14% (n = 49) when all
patients of the included studies were taken into account
(n = 350). Major complications were temporary laryngeal
edema (n = 6, 1.7%), postoperative endolaryngeal hemor-
rhage (n = 3, 0.9%), development of late laryngeal steno-
sis (n = 10, 3.5%) with subsequent late tracheotomy need
(n = 5) or salvage TL (n = 1), postoperative laryngeal
chondritis and/or chondronecrosis (n = 10, 3.5%) with
subsequent tracheotomy need (n = 1) or salvage TL
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(n = 3), and aspiration pneumonia (n = 2, 0.6%). Minor
complications were prolonged (>2 months) postoperative
pain (n = 5, 1.4%), temporary numbness of the tongue
(n = 2, 0.6%), and temporary hypoglossal nerve palsy
(n = 1, 0.3%). Laryngeal synechiae and laryngeal granu-
lation formation developed in seven (2%) and three
(0.9%) cases, respectively, and could be managed by ad-
ditional laser procedures.
Table 2 Functional outcomes and complications of salvage TLM for radiorecurrent laryngeal cancer
Author,
year
Population
size (n)
Mean
hospitalization
time (days)
Post-op tracheostomy
rate and mean duration
(days)
Feeding tube rate
and duration
Complications
Outzen
et al.,
1995
[18]
15 NA 0% 13% (all
supraglottic),
duration NA
Prolonged pain (n = 5)
Quer et al.,
2000
[22]
24 1–5 0% 12.5% (2–4 days) Laryngeal stenosis (n = 2), treated with tracheotomy in 1
case 1 month after TLM
De Gier
et al.,
2001
[23]
44 NA NA NA Chondritis (n = 2) with 1 tracheostomy
Steiner
et al.,
2004
[11••]
34 9 3% (52) 23.5% (2–6 days) Aspiration pneumonia (n = 1), chondronecrosis and TL
(n = 1), AC synechiae (n = 3), laryngeal stenosis and
tracheotomy (n = 1)
Puxeddu
et al.,
2004
[15]
16 2.2 0% 0% None
Ansarin
et al.,
2007
[25]
37 3 0% 0% Laryngeal stenosis (n = 4) with 1 tracheostomy
Piazza
et al.,
2007
[16]
22 4 (3–9) NA NA Late chondritis (n = 1), late chondronecrosis (n = 2)
Roedel
et al.,
2010
[19]
53 NA 0% NG = 13%
(8 days)
G = 4%
(permanent)
Postoperative endolaryngeal hemorrhage (n = 2)
Temporary laryngeal edema (n = 5)
Synechia (n = 4)
Aspiration pneumonia (n = 1)
Chondronecrosis treated with TL (n = 1)
Laryngeal stenosis (n = 3) treated with tracheotomy
(n = 2) and TL (n = 1)
Han et al.,
2012
[24]
18 5.5 (4–42) 22% (4–32) 0% (but NPO in
28% for
2–11 days)
Aspiration pneumonia (n = 1)
Laryngeal tissue granulation (n = 3)
Temporary numbness of tongue (n = 2)
Temporary hypoglossal palsy (n = 1)
Del Bon
et al.,
2012
[17]
35 4 (3–9) 0% 2.9% (7 days) Major postoperative bleeding and revision (n = 1)
Late chondritis (n = 1), late chondronecrosis (n = 2)
Reynolds
et al.,
2013
[20]
10 NA 20% (1 > 4 months) G = 40% (all
>4 months)
NA
Fink et al.,
2016
[21]
42 NA 2% (duration NA) G = 36%
(9.3 months) +
5% (until death)
Postoperative laryngeal edema and tracheotomy (n = 1)
AC anterior commissure, G gastrostomy tube, NA not applicable, NG nasogastric tube, NPO nothing per oral diet, TL total laryngectomy, TLM transoral
laser microsurgery
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Discussion
Oncologic Outcomes
When compared to open partial laryngeal surgery techniques,
salvage TLM as a treatment modality for radiorecurrent laryn-
geal cancer combines good oncologic outcomes with the ad-
vantages of reduced complications, better functional out-
comes in terms of voice and swallowing (lesser rates of tra-
cheostomy and tube feeding), shortened hospitalization time,
and superior cost-effectiveness [7, 16]. However, a trend to-
wards inferior local control rates, even after repeat TLM,
when compared to open partial laryngectomy techniques,
was demonstrated in a recent systematic review and meta-
analysis by Ramakrishnan et al. [8••]. When putting all the
data together, failure of salvage laser treatment alone does not
seem to negatively influence ultimate local control (after sal-
vage TL) and survival (Table 1): the weighted average of local
control rate with TLM alone is 67%, but the ultimate local
control rate, which includes cases that required salvage TL
due to failure of salvage TLM amounted to a weighted aver-
age of 90%. This high rate of ultimate local control is related
to the fact that subsequent recurrences after TLM are generally
contained within the larynx, which can possibly be explained
by preservation of the cartilage during endolaryngeal surgery
without opening the neck [25]. On the contrary, Roedel et al.
did observe a significant decrease in 3- and 5-year overall
(56.6 versus 81.8% and 40.2 versus 70.5%, p = 0.03) and
DSS (48.9 versus 100% each, p = 0.0001) in the group of
patients who developed a second recurrence after the first
salvage TLM procedure [19]. The authors conclude that TL
as an ultimate treatment modality for local failure after salvage
TLM does not preclude a tumor-related death. Nevertheless,
the same authors suggest early TL for ultimate salvage in case
of failure of TLM for the first recurrence. Del Bon et al. also
observed that recurrence after salvage TLM negatively influ-
enced both organ preservation and local control with laser
alone and, when excluding second primary cases, recurrence
after salvage TLM also compromised OS and DSS. This
knowledge prompts us to strongly consider TL or open partial
laryngectomy when a new recurrence occurs after a first TLM
salvage attempt, rather than going for a second salvage TLM
procedure [17].
When compared to local control rates after primary TLM
for laryngeal cancer, which amounts to 94% [27], local control
rates after salvage TLM are inferior. This fact is likely due to
different patterns of tumor growth in the radiorecurrent set-
ting, with the presence of submucosal spread and multifocal
development of recurrences, that can easily be understaged by
endoscopy and imaging [19, 28]. For sure, clinical and radio-
logical evaluation in an often still edematous larynx is more
difficult. Several authors report on frequent understaging of
the radiorecurrent cancer before the TLM procedure. Ansarin
et al. suspected an rT2 recurrent disease in 32% of cases but
eventually identified rT2 and rT3 recurrences in 49% of pa-
tients [25]. Roedel et al. reported that in 60% of patients, rT
stage had been underestimated by preoperative clinical exam-
ination when compared to its true extension as seen during
microsurgical exploration and resection: in 22 out of 53 pa-
tients (42%), advanced-stage recurrence (rT3 and rT4a) was
evident on surgery, although this had only been assumed pre-
operatively in 3 patients (6%). Han et al. reported
understaging in 28% of patients, and sadly but interestingly,
four out of five preoperatively understaged cases recurred af-
ter the first TLM. Because post-irradiation edema and
chondritis pose additional difficulties for the exact preopera-
tive identification of tumor borders, frozen section analysis of
resection margins is proposed by some authors [11••, 22]. The
clinical importance of obtaining free margins was illustrated
by Ansarin et al., who observed a negative influence of the
presence of positive or close margins on recurrence-free sur-
vival (univariate analysis) [25]. Del Bon et al. identified the
status of the surgical margins as a predictor for organ preser-
vation and local control with laser alone, with incomplete
resection with multiple superficial and/or deep positive mar-
gins negatively influencing local control and organ preserva-
tion rates, even after second look procedures [17]. Not surpris-
ingly, extreme effort should always be made to obtain a com-
plete resection with clear margins at the first attempt. Having
this knowledge in mind, a more aggressive resection is neces-
sary in the salvage setting and ultra-narrow margin resections
(e.g., type I and II cordectomies) should be avoided in favor of
wider cordectomies (type III and VI cordectomies—with low
threshold to perform type V and VI cordectomies in our own
experience) [17, 21]. Moreover, surgeon’s experience is con-
sidered of an extreme importance when performing salvage
TLM [11••, 17, 20].
Anterior Commissure Involvement
Obvious involvement of the anterior commissure (AC) in
radiorecurrent carcinoma negatively influences recurrence
rates after salvage TLM. This can be explained by laryn-
geal anatomy: only 2–3 mm separates the AC mucosa
from the thyroid cartilage and there is no perichondrium
at the level of the insertion of the AC tendons into the
thyroid cartilage. As a consequence, tumors of the AC
may invade the thyroid cartilage without any invasion of
the vocalis muscle, and the vocal fold mobility may be
preserved [18]. This may lead to understaging of tumors
involving the AC, which, in combination with increased
difficulty in evaluating the submucosal extension of a
radiorecurrent tumor and the well-known issue of more
difficult exposure, may play a crucial role in the reduced
effectiveness of resection [15]. Irrespective of these ana-
tomical considera t ions , the debate whether AC
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involvement is a contraindication for salvage TLM con-
tinues. De Gier et al. were the first to consider the exten-
sion of the recurrent tumor in the AC as a strict contrain-
dication for salvage TLM. As the local control rate and
laryngeal preservation rate of salvage TLM dropped when
the AC was involved, the authors suggest choosing for an
open salvage conservation surgical approach for these
cases [23]. In contrast to this, Steiner did not consider
the extension of the recurrence into the AC as a contrain-
dication for salvage TLM. Actually, most patients in his
series had AC involvement and no difference was ob-
served in the second recurrence rate between patients with
and without AC involvement (57 versus 54%). However,
in the group of patients with compromised exposure of
AC, more salvage total laryngectomies were performed
(29 versus 8%), hence a lower laryngeal preservation rate
in this group. He concluded that for the experienced TLM
surgeon, AC involvement should not be considered an
absolute contraindication to salvage TLM on the condition
that tumor exposure is adequate [11••]. In line with this
statement, Roedel et al. observed a comparable ultimate
locoregional control and survival, be it at the expense of
a higher rate of salvage laryngectomies, in the group of
patients with AC involvement (39 versus 16%) [19]. In the
same line, Ansarin et al. observed that preoperative suspi-
cion of involvement of the AC had no influence on
recurrence-free survival (univariate analysis; p = 0.45).
The latter report needs to be interpreted with caution, giv-
en the fact that preoperative suspicion of AC involvement
was used to define this subset of patients, rather than the
actual AC involvement as observed during TLM [25]. A
pragmatic approach to this issue was expressed by Piazza
et al., who advised to use extreme caution during salvage
TLM of lesions with involvement of the AC, in view of
deep nests of tumor, invading visceral compartments or
focally involving the laryngeal framework, that could
compromise oncologic outcome. As a consequence, they
suggested performing supracricoid partial laryngectomy
(SCPL) in cases of macroscopic involvement of the AC,
aiming at wider margins of resection [16]. The same re-
search group later supported this statement by identifying
anterior transcommissural extension (above and below the
vocal cords) as a significant negative predictor on overall
survival. However, superficial involvement of the AC lim-
ited to the glottic plane did not negatively affect oncologic
outcomes or organ preservation rate [17]. In line with this,
Han et al. observed that all rT1 tumors with AC involve-
ment were cured with the first TLM, but six out of seven
patients in the rT2 group with AC involvement recurred.
They propose that TLM is appropriate for the treatment of
rT1a and rT1b lesions involving the AC, but promote an
external approach for rT2 lesions with AC involvement
[24].
Functional Outcomes and Complications
The most appealing feature of salvage TLM is that on the one
hand, opening of the thyroid cartilage is avoided, thus mini-
mizing the risk of chondronecrosis and tracheotomy, and on
the other, TLM allows a microscopic tumor-adapted resection,
leaving untouched as much normal larynx as possible [11••,
16, 22]. This results in few complications and superior func-
tional outcomes in terms of voice and swallowing when com-
pared to open partial laryngeal surgery [7]. In reports dealing
with salvage TLM for radiorecurrent laryngeal carcinoma,
few long-term swallowing problems were reported and voice
quality was satisfactory. However, objective measures evalu-
ating swallowing function and voice are lacking in most pub-
lished papers. When vocal outcome was measured, a decrease
after salvage TLM for glottic recurrences was evident [15, 21],
but no significant differences were observed between a sal-
vage and a primary TLM group [17]. As opposed to glottic
recurrences, which exhibited excellent postoperative
swallowing function, supraglottic location of recurrences is
related to postoperative swallowing dysfunction and G-tube
dependency [20, 21]. This finding is supported by Hutcheson
et al., who compared in a retrospective case-control study
functional outcomes of TLM in patients with previously un-
treated supraglottic carcinoma with post-irradiation salvage
cases. Length of feeding tube dependency and rates of chronic
aspiration were significantly higher in the salvage TLM group
[29].
Indications and Limits
A high variability between included papers is observed
regarding indications/contraindications and selection
criteria for salvage TLM of postradiation recurrent cancer.
However, some generally accepted prerequisites for sal-
vage TLM have been identified. To begin with, preoper-
ative imaging (MR or CT) is considered obligatory by all
authors, in order to exclude infiltration of the laryngeal
cartilaginous framework and to quantify involvement of
the paraglottic space. Next, adequate laryngeal exposure
is considered as an absolute necessity for an oncologically
sound transoral resection. In order to estimate the laryn-
geal exposure preoperatively, Piazza et al. developed a
scoring system, the “Laryngoscore,” which proves to be
a good predictor of difficult laryngeal exposure and as-
sists in selecting the ideal candidates for TLM, but which
awaits external validation [30•]. However, developing
their scoring system, the authors identified previous RT,
as well as open-neck surgical approaches, as negative
prognosticators for favorable laryngeal exposure [30•].
Infiltration of the thyroid and cricoid cartilages as detect-
able by CT or MR and extensive infiltration of the soft
t issue of the neck are general ly accepted str ict
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contraindications. Concerning rT status, advanced recur-
rences (rT3 and rT4) can be considered a relative contra-
indication, given the lower local control rates. As
discussed in detail above, AC involvement is not a strict
contraindication for TLM, but the surgeon needs to be
aware of the technical difficulty of treating these lesions
with often disappointing results, especially when gross or
transcommissural involvement is present. A limited de-
gree of subglottic extension (5 mm) of the tumor is toler-
ated by most authors [15, 22, 25] as well as limited
supraglottic spread up to 5 mm above the free edge of
the glottis [25] or not further than the lateral extension
of Morgagni’s sinus [7]. The presence of normal vocal
cord mobility is also considered a selection criterion by
most authors [16, 22, 24], and the arytenoid (except from
the vocal process) needs to be free of tumor [15, 22, 25].
However, Steiner et al. and Roedel et al. only consider
fixation of both vocal cords or arytenoids a contraindica-
tion for salvage TLM [11••, 19]. Some authors consider
any involvement of the paraglottic space (PGS) as a strict
contraindication [16, 25], while others tolerate minimal
involvement of the anterior portion of the PGS [15, 17].
Moreover, the recurrence should correlate with site and
extent of the primary tumor before RT [16, 22]. Finally,
the willingness of the patient to undergo a strict postop-
erative follow-up with regular laryngoscopic examinations
and imaging, allowing for early detection and treatment of
further localized recurrences, is generally considered an
essential key to success [11••, 16, 17, 25]. New advances
in technology such as narrow band imaging (NBI) could
be beneficial in the follow-up of patients who underwent
salvage TLM [31].
Conclusion
If patients are well selected, salvage TLM of radiorecurrent
laryngeal cancer yields good rates of local control with laser
alone and excellent ultimate local control rates, OS and DSS,
when eventual further recurrences are timely and adequately
treated. Serious complications are scarce, hospitalization
times are short, and functional outcomes in terms of voice
and swallowing are favorable when compared to open conser-
vation laryngeal surgery. However, the key to success is an
optimal patient selection, as outcomes are influenced by a
variety of patient-related and tumor-related factors.
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